Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells - PubMed (original) (raw)
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells
S Kagami et al. J Clin Invest. 1994 Jun.
Abstract
Angiotensin II (Ang II) has been implicated in the development of progressive glomerulosclerosis, but the precise mechanism of this effect remains unclear. In an experimental model, we have shown previously that TGF-beta plays a key role in glomerulosclerosis by stimulating extracellular matrix protein synthesis, increasing matrix protein receptors, and altering protease/protease-inhibitor balance, thereby inhibiting matrix degradation. We hypothesized that Ang II contributes to glomerulosclerosis through induction of TGF-beta. Ang II treatment of rat mesangial cells in culture increased TGF-beta and matrix components biglycan, fibronectin, and collagen type I at both the mRNA and protein levels in a time- and dose-dependent manner. Saralasin, a competitive inhibitor of Ang II, prevented the stimulation. Ang II also promoted conversion of latent TGF-beta to the biologically active form. Coincubation of mesangial cells with Ang II and neutralizing antibody to TGF-beta blocked the Ang II-induced increases in matrix protein expression. Continuous in vivo administration of Ang II to normal rats for 7 d resulted in 70% increases in glomerular mRNA for both TGF-beta and collagen type I. These results indicate that Ang II induces mesangial cell synthesis of matrix proteins and show that these effects are mediated by Ang II induction of TGF-beta expression. This mechanism may well contribute to glomerulosclerosis in vivo.
Similar articles
- Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells.
Anderson PW, Zhang XY, Tian J, Correale JD, Xi XP, Yang D, Graf K, Law RE, Hsueh WA. Anderson PW, et al. Kidney Int. 1996 Sep;50(3):745-53. doi: 10.1038/ki.1996.372. Kidney Int. 1996. PMID: 8872947 - Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.
Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA, Border W. Huang Y, et al. Kidney Int. 2006 Jan;69(1):105-13. doi: 10.1038/sj.ki.5000011. Kidney Int. 2006. PMID: 16374430 - Role of angiotensin II in diabetic nephropathy.
Leehey DJ, Singh AK, Alavi N, Singh R. Leehey DJ, et al. Kidney Int Suppl. 2000 Sep;77:S93-8. doi: 10.1046/j.1523-1755.2000.07715.x. Kidney Int Suppl. 2000. PMID: 10997697 Review. - [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A. Ciechanowicz A. Ann Acad Med Stetin. 1999;Suppl 52:1-93. Ann Acad Med Stetin. 1999. PMID: 10589103 Review. Polish.
Cited by
- Research Progress of Triptolide Against Fibrosis.
Jiang M, Xie Y, Wang P, Du M, Wang Y, Yan S. Jiang M, et al. Drug Des Devel Ther. 2024 Jul 25;18:3255-3266. doi: 10.2147/DDDT.S467929. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39081704 Free PMC article. Review. - Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy.
Xie L, Zang D, Yang J, Xue F, Sui W, Zhang Y. Xie L, et al. Front Pharmacol. 2024 May 10;15:1364827. doi: 10.3389/fphar.2024.1364827. eCollection 2024. Front Pharmacol. 2024. PMID: 38799171 Free PMC article. - Response and survival of dogs with proteinuria (UPC > 2.0) treated with angiotensin converting enzyme inhibitors.
Fulton EA, McBrearty AR, Shaw DJ, Ridyard AE. Fulton EA, et al. J Vet Intern Med. 2023 Nov-Dec;37(6):2188-2199. doi: 10.1111/jvim.16864. Epub 2023 Oct 10. J Vet Intern Med. 2023. PMID: 37815154 Free PMC article. - Tetra-ARMS PCR analysis of angiotensinogen AGT T174M (rs4762) genetic polymorphism in diabetic patients: a comprehensive study.
Akash MSH, Shahid M, Suhail S, Rehman K, Nadeem A, Mir TM. Akash MSH, et al. Front Endocrinol (Lausanne). 2023 Aug 25;14:1240291. doi: 10.3389/fendo.2023.1240291. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37693342 Free PMC article. - Time to eRAASe chronic inflammation: current advances and future perspectives on renin-angiotensin-aldosterone-system and chronic intestinal inflammation in dogs and humans.
Heilmann RM, Csukovich G, Burgener IA, Dengler F. Heilmann RM, et al. Front Vet Sci. 2023 Jun 29;10:1180125. doi: 10.3389/fvets.2023.1180125. eCollection 2023. Front Vet Sci. 2023. PMID: 37456955 Free PMC article.
References
- Am J Physiol. 1984 Nov;247(5 Pt 2):F799-807 - PubMed
- J Clin Invest. 1993 Dec;92(6):2597-601 - PubMed
- Nucleic Acids Res. 1985 Mar 11;13(5):1431-42 - PubMed
- J Clin Invest. 1985 Aug;76(2):612-9 - PubMed
- J Biol Chem. 1986 Apr 5;261(10):4377-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous